Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 5/20 | 0.41 |
| ▸ | CA2 | P00918 | 5/20 | 0.41 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | PYGB | P11216 | 1/20 | 0.37 |
| ▸ | AHCY | P23526 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | PPM1B | O75688 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.33 |
| ▸ | CDK1 | P06493 | 1/20 | 0.33 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4107459 | 1.00 | LGALS3 (0.44) | LGALS3CA1CA2CA9PYGB | |
| SCHEMBL30353978 | 1.00 | LGALS3 (0.44) | LGALS3CA1CA2CA9PYGB | |
| SCHEMBL26243844 | 1.00 | LGALS3 (0.44) | LGALS3CA1CA2CA9PYGB | |
| SCHEMBL12085049 | 1.00 | LGALS3 (0.44) | LGALS3CA1CA2CA9PYGB | |
| SCHEMBL1811839 | 1.00 | LGALS3 (0.44) | LGALS3CA1CA2CA9PYGB | |
| SCHEMBL185267 | 1.00 | LGALS3 (0.44) | LGALS3CA1CA2CA9PYGB | |
| SCHEMBL30660898 | 1.00 | LGALS3 (0.44) | LGALS3CA1CA2CA9PYGB | |
| SCHEMBL12082047 | 1.00 | LGALS3 (0.44) | LGALS3CA1CA2CA9PYGB | |
| SCHEMBL7154268 | 1.00 | LGALS3 (0.44) | LGALS3CA1CA2CA9PYGB | |
| SCHEMBL29065825 | 0.98 | LGALS3 (0.43) | LGALS3CA1CA2CA9PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119015137-A | Nanometer microemulsion and preparation method and application thereof | 广州真极和美生物科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| EP-4157853-B1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | GIIANT PHARMA INC (CA) | 2024-07-31 | — | — | EP | claimed |
| CN-115505020-B | Ursolic acid saponin and its preparation method and use | 沈阳药科大学 | 2023-09-12 | — | — | CN | claimed |
| US-20230250123-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | GIIANT PHARMA INC. (CA) | 2023-08-10 | — | — | US | claimed |
| CN-116056713-A | Intestinal microbiota bioactive PDE4 inhibitor precursors | 吉安特制药公司 | 2023-05-02 | — | — | CN | claimed |
| EP-4157853-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | Giiant Pharma Inc. (CA) | 2023-04-05 | — | — | EP | claimed |
| WO-2023040733-A1 | BAICALEIN DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 中国科学院上海药物研究所 | 2023-03-23 | — | — | WO | claimed |
| WO-2022048529-A1 | FORSYTHIAE FRUCTUS COMPONENT AND OPTIONAL GINSENG COMPONENT, AND USE THEREOF | 大连富生天然药物开发有限公司 | 2022-03-10 | — | — | WO | claimed |
| CN-113980931-A | Application of glucuronic acid hydrolase and mutant thereof in preparation of oleanolic acid-beta-D-glucopyranosyl ester | 上海中医药大学 | 2022-01-28 | — | — | CN | claimed |
| WO-2021237364-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | GIIANT PHARMA INC. (CA) | 2021-12-02 | — | — | WO | claimed |
| CN-108409815-B | Indole glycoside substrate, preparation method and application in aerobic flora vaginitis detection | 郑州安图生物工程股份有限公司 | 2021-08-03 | — | — | CN | claimed |
| CN-108883069-B | Esterification/saponification based process for micro-lipid loading | 中央研究院 | 2021-07-20 | — | — | CN | claimed |
| CN-106279318-B | The separation method and flavone composition of flavone compound in calamint | 中国医学科学院药用植物研究所 | 2019-05-03 | — | — | CN | claimed |
| CN-108129530-A | Detect substrate of β-D-Glucose aldehyde neuraminidase and preparation method thereof and kit | 广东优尼德生物科技有限公司 | 2018-06-08 | — | — | CN | claimed |
| CN-106727508-A | A kind of combination drug for treating chronic dysentery | 郑州掌盟网络科技有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106581025-A | Composite western medicine for treating chronic dysentery | 郑州仁宏医药科技有限公司 | 2017-04-26 | — | — | CN | claimed |
| CN-106511440-A | Compound Chinese and Western medicine composition for treating chronic dysentery and preparation method thereof | 郑州仁宏医药科技有限公司 | 2017-03-22 | — | — | CN | claimed |
| EP-0511917-B1 | Glycosylated prodrugs, process for their preparation and uses thereof | HOECHST SA LAB (FR) | 1996-10-23 | — | — | EP | claimed |
| US-5561119-A | ANTITUMOR AGENTS | LABORATOIRES HOECHST (FR) | 1996-10-01 | — | — | US | claimed |
| US-4683222-A | STIMULANTS FOR IMMUNE SYSTEM | BAYER AKTIENGESELLSCHAFT (DE) | 1987-07-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250123-A1 | GUT MICROBIOTA BIOACTIVATED PDE4 INHIBITOR PRECURSORS | PDE4A, PDE4B, PDE4C | LGALS3 2721/4885CA1 2419/4885CA2 1223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.